Angelico Mendy1, Erick Forno2, Theophile Niyonsenga3, Janvier Gasana4. 1. Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa. 2. Division of Pediatric Pulmonary Medicine, Allergy, and Immunology, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Centre for Population Health Research, School of Health Sciences, University of South Australia, Adelaide, South Australia, Australia. 4. Department of Environmental & Occupational Health, Faculty of Public Health, Kuwait University, Jabriya, Kuwait.
Abstract
BACKGROUND: Blood biomarkers are easily accessible and might reflect chronic obstructive pulmonary disease (COPD) activity. AIM: The aim of this study was to determine whether a panel of blood biomarkers [C-reactive protein (CRP), neutrophils, eosinophils, albumin and vitamin D] could predict mortality in COPD. METHODS: We analyzed data from 431 COPD participants to the 2007-2010 National Health and Nutrition Examination Surveys who were followed for a median time of 36 months. COPD was defined as post-bronchodilator forced expiratory volume in 1 second (FEV1) and forced vital capacity ratio <0.70. Weibull survival analysis adjusted for covariates was performed to calculate the risk of mortality associated with the biomarkers, and C-statistics was used to assess their added predictive value. RESULTS: During follow-up, 38 of the 431 participants died. Participants with high CRP, eosinophil count <2%, hypoalbuminemia and hypovitaminosis D had worse baseline FEV1 and subsequently higher mortality compared to controls. In adjusted analysis, increasing CRP [hazard ratio (HR): 4.45, 95% CI: 1.91-10.37] and neutrophil count (HR: 1.07, 95% CI: 1.03-1.11) as well as decreasing eosinophil count (HR: 7.03, 95% CI: 2.05-24.01) were associated with an increased risk of mortality. The addition of CRP with eosinophil and/or neutrophil count significantly improved a base model for the prediction of mortality which included age, gender, race/ethnicity, body mass index, smoking, poverty income ratio, asthma, diabetes, hypertension and history of stroke or myocardial infarction. CONCLUSION: High CRP and neutrophils as well as low eosinophils are predictive of poor COPD prognosis. They also add significant value to prediction models of mortality in COPD.
BACKGROUND: Blood biomarkers are easily accessible and might reflect chronic obstructive pulmonary disease (COPD) activity. AIM: The aim of this study was to determine whether a panel of blood biomarkers [C-reactive protein (CRP), neutrophils, eosinophils, albumin and vitamin D] could predict mortality in COPD. METHODS: We analyzed data from 431 COPDparticipants to the 2007-2010 National Health and Nutrition Examination Surveys who were followed for a median time of 36 months. COPD was defined as post-bronchodilator forced expiratory volume in 1 second (FEV1) and forced vital capacity ratio <0.70. Weibull survival analysis adjusted for covariates was performed to calculate the risk of mortality associated with the biomarkers, and C-statistics was used to assess their added predictive value. RESULTS: During follow-up, 38 of the 431 participants died. Participants with high CRP, eosinophil count <2%, hypoalbuminemia and hypovitaminosis D had worse baseline FEV1 and subsequently higher mortality compared to controls. In adjusted analysis, increasing CRP [hazard ratio (HR): 4.45, 95% CI: 1.91-10.37] and neutrophil count (HR: 1.07, 95% CI: 1.03-1.11) as well as decreasing eosinophil count (HR: 7.03, 95% CI: 2.05-24.01) were associated with an increased risk of mortality. The addition of CRP with eosinophil and/or neutrophil count significantly improved a base model for the prediction of mortality which included age, gender, race/ethnicity, body mass index, smoking, poverty income ratio, asthma, diabetes, hypertension and history of stroke or myocardial infarction. CONCLUSION: High CRP and neutrophils as well as low eosinophils are predictive of poor COPD prognosis. They also add significant value to prediction models of mortality in COPD.
Authors: Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol Journal: JAMA Date: 2003-08-20 Impact factor: 56.272
Authors: Bartolome R Celli; Nicholas Locantore; Julie Yates; Ruth Tal-Singer; Bruce E Miller; Per Bakke; Peter Calverley; Harvey Coxson; Courtney Crim; Lisa D Edwards; David A Lomas; Annelyse Duvoix; William MacNee; Stephen Rennard; Edwin Silverman; Jørgen Vestbo; Emiel Wouters; Alvar Agustí Journal: Am J Respir Crit Care Med Date: 2012-03-15 Impact factor: 21.405
Authors: Mona Bafadhel; Lisa Davies; Peter M A Calverley; Shawn D Aaron; Christopher E Brightling; Ian D Pavord Journal: Eur Respir J Date: 2014-06-12 Impact factor: 16.671
Authors: Ian D Pavord; Sally Lettis; Nicholas Locantore; Steve Pascoe; Paul W Jones; Jadwiga A Wedzicha; Neil C Barnes Journal: Thorax Date: 2015-11-19 Impact factor: 9.139
Authors: Paivi M Salo; Angelico Mendy; Jesse Wilkerson; Samantha A Molsberry; Lydia Feinstein; Stephanie J London; Michael B Fessler; Peter S Thorne; Darryl C Zeldin Journal: Respir Res Date: 2022-06-09
Authors: Robert M Burkes; Agathe S Ceppe; Claire M Doerschuk; David Couper; Eric A Hoffman; Alejandro P Comellas; R Graham Barr; Jerry A Krishnan; Christopher Cooper; Wassim W Labaki; Victor E Ortega; J Michael Wells; Gerard J Criner; Prescott G Woodruff; Russell P Bowler; Cheryl S Pirozzi; Nadia N Hansel; Robert A Wise; Todd T Brown; M Bradley Drummond Journal: Chest Date: 2020-01-17 Impact factor: 9.410
Authors: Emma L Carson; L Kirsty Pourshahidi; Sharon M Madigan; Francina R Baldrick; Martin G Kelly; Eamon Laird; Martin Healy; J J Strain; Maria S Mulhern Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-08-28
Authors: Robson Prudente; Renata Ferrari; Carolina B Mesquita; Luiz H S Machado; Estefânia A T Franco; Irma Godoy; Suzana E Tanni Journal: Int J Chron Obstruct Pulmon Dis Date: 2021-04-14